Endocyte Announces Third Quarter 2015 Earnings Conference Call
October 27, 2015 16:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., Oct. 27, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc., (NASDAQ:ECYT) announced today that the company will host a conference call on Tuesday, Nov. 3rd, at 4:30 p.m. EST to discuss its...
Endocyte to Present Data on EC1456 at the European Cancer Congress 2015
September 21, 2015 16:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., Sept. 21, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
Endocyte Announces Final Overall Survival Results From Phase 2b TARGET Trial in Non-Small Cell Lung Cancer Patients
September 07, 2015 14:45 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., Sept. 7, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), today presented the final overall survival (OS) analysis from the Phase 2b TARGET trial evaluating its small...
Endocyte to Present at Upcoming Healthcare Conferences
September 03, 2015 16:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., Sept. 3, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for...
Endocyte Announces Presentations at the 250th American Chemical Society National Meeting & Exposition
August 12, 2015 16:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., Aug. 12, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a bio-pharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and...
Endocyte Reports Second Quarter 2015 Financial Results and Provides Update on Clinical Progress
August 04, 2015 16:01 ET
|
Endocyte, Inc.
- Dose Escalation for EC1456 and EC1169 Advance in Phase 1 Studies -
- Final Overall Survival Analysis From TARGET Trial of EC145 in NSCLC to be Presented at the World Conference on Lung Cancer...
Endocyte Appoints Dr. Alison A. Armour as Chief Medical Officer
August 04, 2015 07:30 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT) a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion...
Endocyte to Present at the 2015 Wedbush PacGrow Healthcare Conference
August 03, 2015 16:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., Aug. 3, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion...
Endocyte Announces Second Quarter 2015 Earnings Conference Call
July 28, 2015 16:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., July 28, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc., (NASDAQ:ECYT) announced today that the company will host a conference call on Tuesday, Aug. 4th, at 4:30 p.m. EDT to discuss its...
Endocyte to Present at the Cantor Fitzgerald Healthcare Conference
July 01, 2015 16:01 ET
|
Endocyte, Inc.
WEST LAFAYETTE, Ind., July 1, 2015 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion...